Suggested Best Practices for ClinicalTrials.gov Activity during the COVID-19 Pandemic

About this resource

This document is targeted to academic researchers and institutions, and complements the ClinicalTrials.gov resource titled "Responses to Top Questions from Responsible Parties Related to Coronavirus (COVID-19)," which is linked to in this document.

Download Resource

• Best Practices